What is Versigent 's cash and cash equivalents, end of period?

Versigent (VGNT) reported cash and cash equivalents, end of period of $282M in Q1 2026.

Versigent VGNT Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66PSX

$5.15B+246%

Arthur J. GallagherAJG

$8.48B-61.9%

3MMMM

$3.73B-41.1%

eBayEBAY

$4.23B+1.9%

American Financial GroupAFG

$1.35B+6.0%

Erie Indemnity CompanyERIE

$268.62M+3.2%

Other financials

Income statement

See full

Revenue$2.2B+9.3%

Gross profit$244.0M-2.0%

Operating income$74.0M-39.8%

Net income$78.0M-17.9%

Balance sheet

See full

Cash & equivalents$282.0M—

Total debt$2.4B—

Total equity-$48.0M-103%

Total assets$4.9B—

Cash flow

See full

Operating cash flow$36.0M-10.0%

CapEx$66.0M+78.4%

Free cash flow-$30.0M-1,100%

Valuation

See full

Market cap$3.03B—

Returns & leverage

See full

Debt / equity0.2×—

Current ratio1.4×—

Where this comes from

Reported directly by Versigent in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Versigent ’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Versigent 's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Versigent 's cash and cash equivalents, end of period?: Versigent (VGNT) reported cash and cash equivalents, end of period of $282M in Q1 2026.